97 filings
Page 2 of 5
8-K
z51 0h9bi05sbmc0a8qb
19 Jan 24
Entry into a Material Definitive Agreement
5:29pm
8-K
iwlkh5eb c9
11 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
m1j62zac
6 Dec 23
Regulation FD Disclosure
5:00pm
8-K
8pmh5
5 Dec 23
Regulation FD Disclosure
7:30am
8-K
rz52d4 cuem442sgfq
17 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
el4d3fsduaqhhid68t
13 Nov 23
Regulation FD Disclosure
8:35am
8-K
b2nsm19yz4wetab
30 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
h10dx 0idb72
27 Sep 23
Material Modifications to Rights of Security Holders
4:30pm
8-K
k5cq9 ss5kmju9cxk
15 Sep 23
Entry into a Material Definitive Agreement
8:45am
8-K
e20nhej49s313egtxz
11 Aug 23
Departure of Directors or Certain Officers
8:15am
8-K
yb1ssiturpbo
27 Jul 23
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
4:01pm
8-K
8155b2ydtrlc
17 Jul 23
Other Events
5:10pm
8-K
4dlwie6
11 Jul 23
Entry into a Material Definitive Agreement
4:05pm
8-K
hlk79e gimdeaergxqwd
6 Jul 23
Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering
6:05am
8-K
dffm1d3y8 40kg
5 Jul 23
Other Events
4:31pm
8-K
ht6h4um0bfxw1s mf
30 Jun 23
Entry into a Material Definitive Agreement
4:05pm
8-K
x1og emks4
28 Jun 23
Allarity Therapeutics Announces Reverse Stock Split of
4:01pm
8-K
7bmykeey
23 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
vyjruvue9a51z5k8wx5m
20 Jun 23
Allarity Therapeutics Announces Adjournment of Special Meeting of Stockholders
4:30pm
8-K
hdycypxrwikmh7ag
1 Jun 23
Entry into a Material Definitive Agreement
5:00pm